---
title: cutanos
date: 2021-07-05T06:53:41Z
modified: 2026-08-11T08:23:19Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/cutanos/"
type: portfolio
status: publish
excerpt: ""
wpid: 89008
language:
  - English
post_translations:
  - pll_60c8815359436
branchen22:
  - Drug Delivery
sectors:
  - Pharmaceuticals
focus_areas:
  - Immunology
timestamp: 2026-08-11T08:23:19Z
tags:
  - English
  - pll_60c8815359436
  - Drug Delivery
  - Pharmaceuticals
  - Immunology
---

## Beschreibungstext

Cutanos GmbH is a biotech company founded in early 2021 focussing on the development of antigen-specific vaccines and new treatments for autoimmune disorders. Cutanos uses a modular and highly flexible drug delivery system called the Langerhans Cell Targeted Delivery System (LC-TDS). With this technology, the company aims to realize innovative immunotherapies in conjunction with minimally invasive administration. As a spin-off of the Max Planck Institute of Colloids and Interfaces, Cutanos will demonstrate the full range of its platform technology from their headquarter in Austrian capital of Vienna, financed by an equally motivated investment consortium (including KHAN-I, HTGF and IST cube).

## Unternehmenswebsite

> [Website](https://cutanos.com/)

## Adresse

Cutanos GmbH
A-1090 Wien, Althanstrasse 14 (UZA II)

## Kontakt

Array

Array

Array